Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Zhejiang CONBA Pharmaceutical Co Ltd cash flow-to-debt ratio. Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥133.43 Million could theoretically repay 0% of its total liabilities (CN¥2.97 Billion) in one year. Check cash flow quality index of Zhejiang CONBA Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Cash flow-to-debt ratio of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. Historical debt coverage capacity for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Check 600572 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang CONBA Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2003–2025)
Zhejiang CONBA Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for Zhejiang CONBA Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang CONBA Pharmaceutical Co Ltd (600572) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥942.61 Million | CN¥2.83 Billion | ▼ -1.7% |
| 2024 | 0.34x | CN¥1.01 Billion | CN¥2.99 Billion | ▲ +46.6% |
| 2023 | 0.23x | CN¥898.64 Million | CN¥3.89 Billion | ▼ -27.9% |
| 2022 | 0.32x | CN¥1.16 Billion | CN¥3.61 Billion | ▲ +22.4% |
| 2021 | 0.26x | CN¥889.94 Million | CN¥3.40 Billion | ▼ -17.7% |
| 2020 | 0.32x | CN¥1.25 Billion | CN¥3.93 Billion | ▲ +69.0% |
| 2019 | 0.19x | CN¥925.50 Million | CN¥4.92 Billion | ▲ +69.7% |
| 2018 | 0.11x | CN¥545.78 Million | CN¥4.92 Billion | ▼ -44.3% |
| 2017 | 0.20x | CN¥712.27 Million | CN¥3.58 Billion | ▼ -17.7% |
| 2016 | 0.24x | CN¥969.71 Million | CN¥4.01 Billion | ▲ +45.7% |
| 2015 | 0.17x | CN¥831.26 Million | CN¥5.00 Billion | ▼ -21.2% |
| 2014 | 0.21x | CN¥617.43 Million | CN¥2.93 Billion | ▲ +66.8% |
| 2013 | 0.13x | CN¥235.36 Million | CN¥1.86 Billion | ▲ +7.9% |
| 2012 | 0.12x | CN¥245.76 Million | CN¥2.10 Billion | ▼ -16.1% |
| 2011 | 0.14x | CN¥188.36 Million | CN¥1.35 Billion | ▼ -17.1% |
| 2010 | 0.17x | CN¥125.93 Million | CN¥747.34 Million | ▼ -14.2% |
| 2009 | 0.20x | CN¥153.39 Million | CN¥780.76 Million | ▲ +29.5% |
| 2008 | 0.15x | CN¥98.56 Million | CN¥649.60 Million | ▲ +31.5% |
| 2007 | 0.12x | CN¥79.98 Million | CN¥693.32 Million | ▲ +1.8% |
| 2006 | 0.11x | CN¥71.20 Million | CN¥628.20 Million | ▼ -46.0% |
| 2005 | 0.21x | CN¥117.65 Million | CN¥560.55 Million | ▲ +33.5% |
| 2004 | 0.16x | CN¥65.47 Million | CN¥416.37 Million | ▼ -19.2% |
| 2003 | 0.19x | CN¥66.64 Million | CN¥342.22 Million | — |